Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqGS - Nasdaq Real Time Price USD

Cantaloupe, Inc. (CTLP)

8.22
+0.06
+(0.74%)
At close: May 7 at 4:00:00 PM EDT

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 73.72M
Earnings 5.89M

Q1'24

Q2'24

Q3'24

Q4'24

0
20M
40M
60M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

11.50
12.50 Average
8.22 Current
14.00 High

Earnings Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 2222
Avg. Estimate 0.10.120.350.51
Low Estimate 0.10.110.330.49
High Estimate 0.110.130.380.53
Year Ago EPS 0.10.040.250.35

Revenue Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 6666
Avg. Estimate 79.83M85.5M309.9M357.79M
Low Estimate 77.86M83.03M305.44M347.65M
High Estimate 82.3M88.5M315.4M367.6M
Year Ago Sales 67.9M72.66M268.6M309.9M
Sales Growth (year/est) 17.58%17.67%15.38%15.45%

Earnings History

Currency in USD 3/31/2024 6/30/2024 9/30/2024 12/31/2024
EPS Est. 0.070.050.040.07
EPS Actual 0.10.040.060.08
Difference 0.03-0.020.030.01
Surprise % 44.76%-29.27%72.08%12.71%

EPS Trend

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Current Estimate 0.10.120.350.51
7 Days Ago 0.10.120.350.51
30 Days Ago 0.10.120.350.51
60 Days Ago 0.10.120.350.51
90 Days Ago 0.110.120.360.51

EPS Revisions

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days --11--
Up Last 30 Days --11--
Down Last 7 Days 1111
Down Last 30 Days 1111

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
CTLP 3.62%208.48%41.32%43.66%
S&P 500 12.50%3.24%7.95%13.84%

Upgrades & Downgrades

Maintains Barrington Research: Outperform to Outperform 3/27/2025
Maintains Benchmark: Buy to Buy 2/26/2025
Maintains Barrington Research: Outperform to Outperform 2/12/2025
Maintains Barrington Research: Outperform to Outperform 2/7/2025
Maintains Barrington Research: Outperform to Outperform 2/3/2025
Maintains Northland Capital Markets: Outperform to Outperform 11/11/2024

Related Tickers